Patents
Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
03/2007
03/06/2007US7186825 Polyamines for treatment of diseases such as cancer or treatment of tumors
03/06/2007US7186753 nitroso derivatives of drugs such as antiinflammatory agents, antibiotics, expectorants, mucolytic agents, antidiabetics, antitumor, viricides, enzyme inhibitors bronchodilators and antiulcer agents
03/06/2007US7186752 Derivatives of N-(iminomethyl)amines, their preparation, their use as medicaments and the pharmaceutical compositions containing them
03/06/2007US7186732 For therapy and prophylaxis of upper airway allergic response, nasal congestion, or allergic rhinitis, dementia, mild cognitive impairment (pre-dementia), cognitive dysfunction, schizophrenia, depression, manic disorders
03/06/2007US7186725 Anti-inflammatory compositions and methods
03/06/2007US7186724 central nervous system disorders; psychological disorders; Parkinson's disease; Huntington's disease ; sleep disorders
03/06/2007US7186719 Antibacterial agents
03/06/2007US7186717 Pyrrolidine derivatives as Factor Xa inhibitors
03/06/2007US7186495 (Meth) acrylate derivative, polymer and photoresist composition having lactone structure, and method for forming pattern by using it
03/06/2007CA2168319C 4-mercaptobenzoylguanidine derivatives
03/06/2007CA2129159C Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
03/01/2007WO2007022845A1 Novel materials for organic electroluminescent devices
03/01/2007WO2006081273A8 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroayryl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immunostimulant activity
03/01/2007US20070049635 Diamine derivatives, process for producing the same, and plant disease control agents containing the same as active ingredients
03/01/2007US20070049601 BENZOFURAN INHIBITORS OF FACTOR VIIa
03/01/2007CA2611736A1 Benzo[b]furane and benzo[b]thiophene derivatives
02/2007
02/28/2007EP1757597A1 Method for producing 2-oxo-1-phenyl-3-oxabicyclo¬3.1.0|hexane
02/28/2007EP1756107A2 Aryl-substituted piperazine derivatives
02/28/2007EP1756062A1 Compounds and compositions as ppar modulators
02/28/2007EP1756058A1 Histamine-3 receptor antagonists
02/28/2007EP1756054A1 3-amino-1-arylpropyl indoles as monoamine reuptake inhibitor
02/28/2007EP1756044A1 Therapeutic compounds
02/28/2007EP1756043A1 Ortho substituted aryl or heteroaryl amide compounds
02/28/2007EP1755585A1 Transthyretin stabilization
02/28/2007EP1458703B1 Isochroman compounds for treatment of cns disorders
02/28/2007EP1415987B1 Nitrogenous aromatic ring compounds as anti cancer agents
02/28/2007EP1343561B1 Serine protease inhibitors
02/28/2007EP1265606B9 Cell adhesion inhibitors
02/28/2007EP1240154B1 Serine protease inhibitors
02/28/2007CN1922161A Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same in therapeutics
02/28/2007CN1921907A 组织蛋白酶半胱氨酸蛋白酶抑制剂 Cathepsin cystatin
02/28/2007CN1921845A Furosemide derivatives as modulators of HM74 and their use for the treatment of inflammation
02/28/2007CN1919856A Caulis trachelospermi total lignans extractive, extraction method and medicine use of the extractive and active constituent thereof
02/28/2007CN1302339C Photo sensitive resin composition
02/28/2007CN1301986C Process for preparation of prostaglandins and analogues thereof
02/28/2007CN1301985C Method for extracting Vitamin C and gulonic acid from Vitamin C mother liquor
02/28/2007CN1301984C Catalysis method for synthesizing gamma butyrolactone
02/28/2007CN1301974C Muller Klaus-helmut
02/28/2007CN1301964C Inhibitors of alpha 4 mediated cell adhesion
02/27/2007US7183436 Substituted 4-aminocyclohexanols
02/27/2007US7183423 Reacting an alcohol with an acrylic acid or acrylate compound to form an alpha-hydroxy-gamma-butyrolactone compound, using N-hydroxyphthalimide as catalyst for example
02/27/2007US7183411 Naphthol, quinoline and isoquinoline-derived urea modulators of vanilloid VR1 receptor
02/27/2007US7183320 For therapy of neoplastic diseases
02/27/2007US7183318 Substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
02/27/2007US7183300 Compounds that inhibit Hiv formation for viricides and inhibition of capsid formation
02/27/2007US7183298 Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitors
02/27/2007US7183297 For therapy of rheumatoid arthritis, osteoarthritis, asthma, psoriasis, eczema, allergic rhinitis, allergic conjunctivitis, adult respiratory distress syndrome, chronic pulmonary inflammation, chronic obstructive pulmonary disease, chronic heart failure, silicosis, endotoxemia, toxic shock syndrome
02/27/2007US7183286 Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (BVDV) infection and hepatitis C virus (HCV) infection
02/27/2007US7183260 C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases
02/27/2007CA2225939C Process for the production of carbonyl compound
02/22/2007WO2007020631A2 Tetracyclic benzofuran derivatives with therapeutic activities
02/22/2007WO2006134163A8 Novel tetracyclic tetrahydrofuran derivatives containing a cyclic amine side chain
02/22/2007WO2006116218A8 Crystal forms of {[(2r)-7-(2,6-dichlorophenyl)-5-fluoro-2,3-dihydro-1-benzofuran-2-yl]methyl}amine hydrochloride
02/22/2007WO2006113557A3 Gpcr modulators
02/22/2007US20070043187 Perfluoro-4-methyl-2-methylene-1,3-dioxolane, for example, prepared by reacting mixture of 2-chloro-1-propanol and 1-chloro-2-propanol with methyl trifluoropyruvate; useful as an optical or electrical materials
02/22/2007US20070043090 Novel Sulfonamides
02/22/2007US20070043077 Aryl-carbaldehyde oxime derivatives and their use as estrogenic agents
02/22/2007US20070040164 Polymer complex compound and polymer light emitting device using the same
02/22/2007DE69530936C5 Boronsäure-und-esterverbindungen, deren systhese und verwendungen Boronic acid and ester compounds whose systhese and uses
02/21/2007EP1754707A2 Multicyclic compounds and their use as inhibitors of PARP, VEGFR2 and MLK3 enzymes
02/21/2007EP1754705A2 Antagonists for treatment of CD11/CD18 adhesion receptor mediated disorders
02/21/2007EP1754700A2 Synthesis of oligoketides
02/21/2007EP1753713A2 Synthesis of tetracyclines and analogues thereof
02/21/2007EP1551797B1 Cyclohexyl sulphone derivatives as gamma-secretase inhibitors
02/21/2007EP1519726B1 Utilization of heteroarene carboxamide as dopamine-d3 ligands for the treatment of cns diseases
02/21/2007EP1478614B1 Method for producing phthalic anhydride
02/21/2007EP1311482B1 Non-imidazole aryloxypiperidines as h3 receptor ligands
02/21/2007CN1918145A Amino heterocyclic modulators of chemokine receptor activity
02/21/2007CN1918122A Novel benzofurans and indols
02/21/2007CN1918112A Method for the separation of intermediates which may be used for the preparation of escitalopram
02/21/2007CN1918095A Hydrogenation method for producing optically active alcohols or carboxylic acids
02/21/2007CN1918094A Method for producing optically active alcohols or carboxylic acids
02/21/2007CN1915986A High purified tanshinone óÄA sodium sulfonate, fabricating method, and preparation
02/21/2007CN1915985A Method for producing maleic anhydride of hydriding terpene
02/21/2007CN1915984A Method for preparing whisky lactone
02/21/2007CN1915952A Method for extracting protocatechualdehyde and salviol acid from red sage root
02/21/2007CN1915231A Use of nonsteroidal in preparing drug of antiinflammatory agents
02/20/2007US7179941 N-{3-[3-(2-Chloro-4,5-difluorobenzoyl)ureido]-4-methoxyphenyl}acetamide; treating type 2 diabetes
02/20/2007US7179918 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
02/20/2007US7179912 Materials and methods to potentiate cancer treatment
02/20/2007US7179840 Furancarboxamides
02/20/2007US7179839 For therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction
02/20/2007US7179819 Benzyl -urea, -thiourea, or -guanidine derivatives that inhibit the binding of ligands to alpha 4 beta 1 integrin (VLA-4); for therapy and prophylaxis of pathologies associated with VLA-4 mediated cell adhesion, such as inflammatory and autoimmune diseases, and tumor metastasis
02/20/2007US7179817 For therapy and prophylaxis of peripheral arterial disease such as arteriosclerosis obliterans, thromboangiitis obliterans, Buerger's disease or diabetic neuropathy, sepsis, angiitis, nephritis, pneumonia, stroke, myocardial infarction, edematous state, atherosclerosis, varicosity such as hemorrhoid
02/15/2007WO2007018439A1 Conducting polymers and uses thereof
02/15/2007WO2007018194A1 Method for producing cercosporamide
02/15/2007WO2007018193A1 Novel cercosporamide derivative
02/15/2007WO2007017267A2 Novel compounds
02/15/2007WO2007017093A1 Substituted 2-benzyloxy-benzoic acid amide derivatives
02/15/2007WO2007002410A3 Core-modified terpene trilactones from ginkgo biloba extract and biological evaluation thereof
02/15/2007WO2006055472A3 Synthetic discodermolide analogs
02/15/2007WO2005092897A3 2,4,6-phenylsubstituted cyclic ketoenoles
02/15/2007US20070037976 Method for producing an optically active nitro compound
02/15/2007US20070037858 Hexyl carboxanilides and their use for controlling undesirable micro-organisms
02/15/2007US20070037814 ACYLSULFAMIDE INHIBITORS OF FACTOR VIIa
02/15/2007US20070037778 Therapy and prophylaxis of Alzheimer's Disease and Down's syndrome; inhibiting beta amyloid production; 2,4-difluoro-N-[(1S,2S)-1-(hydroxymethyl)-2-methylbutyl]benzenesulfonamide
02/15/2007US20070037752 Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases
02/15/2007DE19852894B4 Verfahren zur Gewinnung von Phthalsäureanhydrid durch katalytische Gasphasenreaktion und Vorrichtung zur Durchführung des Verfahrens A process for the production of phthalic anhydride by catalytic gas-phase reaction, and apparatus for carrying out the method
02/15/2007DE102005037925A1 New hydro-cyclopentanaphthalene compound, useful as a component for a liquid crystalline medium, which is used as a component for an electrooptical display element
02/15/2007CA2618888A1 Acyltryptophanols for fertility control